Blood Group Typing Market – Overview
This report studies the current as well as future prospects of the global blood group typing market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of products for blood group typing and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global blood group typing market with respect to the leading segments based on product, technique, test, end-user, and region.
Based on product, the global blood group typing market has been categorized into instruments [automated, semi-automated, and manual], consumables (reagent, test kits, antisera, others) and services. In terms of technique, the market has been classified into PCR-based, microarray-based, assay-based technique, and massively parallel technique. Based on test, the market has been segregated into antibody screening, HLA typing, ABO blood test, cross matching test, and antigen typing. Based on end-user, the global blood group typing market has been divided into hospitals, clinical laboratories, blood bank, and others.
Each of the segments has been extensively analyzed based on market related factors such as incidence and prevalence of major chronic diseases. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.
Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=48627
The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the blood group typing market and is likely to influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players has been evaluated through market share analysis in the competitive landscape section of the report. All these factors are expected to help market players take strategic decisions in order to strengthen their positions and expand their shares in the global blood group typing market.
In terms of geography, the global blood group typing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides the market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share Analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global blood group typing market.
Key players operating in the global blood group typing market include Grifols, S. A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., Beckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., Rapid Labs Ltd, and Novacyt Group.